Feb 27, 2026 09:05AM
Feb 26, 2026 07:46AM
Jan 30, 2026 08:58AM
Jan 28, 2026 06:44AM
Jan 27, 2026 06:56AM
Jan 6, 2026 03:20PM
Dec 19, 2025 04:01PM Aclaris Therapeutics added to NASDAQ Biotechnology Index
Nov 6, 2025 08:14AM
Oct 15, 2025 07:13AM
Aug 7, 2025 08:35AM
Jul 29, 2025 04:02PM
Jul 28, 2025 08:45AM
Jul 9, 2025 04:36PM
Jun 30, 2025 09:32AM Aclaris Therapeutics (ACRS) Added to the Russell 2000 and Russell 3000 Indexes
Jun 25, 2025 06:42AM
Jun 9, 2025 06:44AM
Jun 2, 2025 07:02AM
May 28, 2025 07:06AM
May 28, 2025 07:05AM
May 14, 2025 07:52AM
May 8, 2025 04:31PM Aclaris Therapeutics (ACRS) Tops Q1 EPS by 2c
Apr 29, 2025 07:02AM
Apr 22, 2025 06:59AM
Mar 7, 2025 07:06AM
Feb 27, 2025 07:02AM
Feb 12, 2025 06:51AM
Jan 30, 2025 04:04PM
Dec 23, 2024 06:46AM H.C. Wainwright Upgrades Aclaris Therapeutis (ACRS) to Buy
Dec 19, 2024 04:34PM
Nov 20, 2024 03:46PM
Nov 19, 2024 11:07AM
Nov 19, 2024 07:19AM
Nov 19, 2024 02:35AM
Nov 19, 2024 02:34AM
Nov 18, 2024 02:54PM Piper Sandler Upgrades Aclaris Therapeutis (ACRS) to Overweight, PT $13
Nov 18, 2024 12:34PM
Nov 18, 2024 08:11AM
Nov 18, 2024 08:10AM
Nov 6, 2024 12:46PM
Sep 18, 2024 06:44AM
Sep 18, 2024 06:21AM
Jul 16, 2024 04:03PM Aclaris Therapeutics (ACRS) Sells OLUMIANT Royalties and Milestones to OMERS Life Sciences for Up to $31.5M

353,174 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All